BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37808149)

  • 1. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
    Guo H; Fan Q
    Evid Based Complement Alternat Med; 2021; 2021():5970085. PubMed ID: 34221079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma
    Li Z; Fei H; Lei S; Hao F; Yang L; Li W; Zhang L; Fei R
    PeerJ; 2021; 9():e12624. PubMed ID: 35036134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the association between HMMR expression and progression of hepatocellular carcinoma via construction of a co-expression network.
    Lu D; Bai X; Zou Q; Gan Z; Lv Y
    Oncol Lett; 2020 Sep; 20(3):2645-2654. PubMed ID: 32765791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.
    International BR
    Biomed Res Int; 2024; 2024():9784513. PubMed ID: 38230025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis.
    International BR
    Biomed Res Int; 2023; 2023():9762109. PubMed ID: 38075323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9806936. PubMed ID: 37502585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach.
    Markers D
    Dis Markers; 2023; 2023():9836354. PubMed ID: 37744889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Identification of Novel Biomarkers Related to Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9780526. PubMed ID: 38094439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleate acid-stimulated HMMR expression by CEBPα is associated with nonalcoholic steatohepatitis and hepatocellular carcinoma.
    Zhang D; Liu J; Xie T; Jiang Q; Ding L; Zhu J; Ye Q
    Int J Biol Sci; 2020; 16(15):2812-2827. PubMed ID: 33061798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9834327. PubMed ID: 37860371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9782763. PubMed ID: 37503422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Hub Gene Screening and Prognostic Modeling of Lung Cancer: An Integrated Bioinformatics Study.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9834087. PubMed ID: 37475946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Bioinformatics Analysis Identifies
    Markers D
    Dis Markers; 2023; 2023():9894804. PubMed ID: 37886108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9809678. PubMed ID: 37538093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9760920. PubMed ID: 38094413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
    Oncology JO
    J Oncol; 2023; 2023():9803262. PubMed ID: 37869587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Identification of Key Genes in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9836790. PubMed ID: 38074350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Integrated Bioinformatics Identifies FREM1 as a Diagnostic Gene Signature for Heart Failure.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9803720. PubMed ID: 38075139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9815947. PubMed ID: 37565164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.